Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.
Saved in:
| Title: | Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. |
|---|---|
| Authors: | Grossman D; Huntsman Cancer Institute, Salt Lake City, Utah.; Department of Dermatology, University of Utah, Salt Lake City.; Department of Oncological Sciences, University of Utah, Salt Lake City., Okwundu N; Huntsman Cancer Institute, Salt Lake City, Utah., Bartlett EK; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Marchetti MA; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Othus M; Fred Hutchinson Cancer Research Center, Seattle, Washington., Coit DG; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Hartman RI; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Department of Dermatology, Harvard Medical School, Boston, Massachusetts., Leachman SA; Department of Dermatology and Knight Cancer Institute, Oregon Health & Science University, Portland., Berry EG; Department of Dermatology and Knight Cancer Institute, Oregon Health & Science University, Portland., Korde L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Lee SJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Department of Data Sciences, Harvard Medical School, Boston, Massachusetts., Bar-Eli M; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston., Berwick M; Departments of Dermatology and Internal Medicine, University of New Mexico Cancer Center, University of New Mexico, Albuquerque., Bowles T; Department of Surgery, Division of Surgical Oncology, University of Utah, Salt Lake City., Buchbinder EI; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Department of Internal Medicine, Harvard Medical School, Boston, Massachusetts., Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Chu EY; Department of Dermatology, Perelman School of Medicine University of Pennsylvania, Philadelphia., Curiel-Lewandrowski C; Department of Dermatology and University of Arizona Cancer Center, University of Arizona, Tucson., Curtis JA; Department of Dermatology, University of Utah, Salt Lake City., Daud A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.; Department of Hematology/Oncology, University of California, San Francisco., Deacon DC; Department of Dermatology, University of Utah, Salt Lake City., Ferris LK; Department of Dermatology and University of Pittsburgh Clinical and Translational Science Institute, Pittsburgh, Pennsylvania., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Grossmann KF; Huntsman Cancer Institute, Salt Lake City, Utah.; Department of Medicine, Division of Oncology, University of Utah, Salt Lake City., Hu-Lieskovan S; Huntsman Cancer Institute, Salt Lake City, Utah.; Department of Medicine, Division of Oncology, University of Utah, Salt Lake City., Hyngstrom J; Huntsman Cancer Institute, Salt Lake City, Utah.; Department of Surgery, Division of Surgical Oncology, University of Utah, Salt Lake City., Jeter JM; Department of Internal Medicine and The Ohio State University Comprehensive Cancer Center, Columbus., Judson-Torres RL; Huntsman Cancer Institute, Salt Lake City, Utah.; Department of Dermatology, University of Utah, Salt Lake City., Kendra KL; Department of Internal Medicine and The Ohio State University Comprehensive Cancer Center, Columbus., Kim CC; Department of Dermatology, Tufts Medical Center, Boston, Massachusetts.; Partners Healthcare, Newton Wellesley Dermatology Associates, Wellesley, Massachusetts., Kirkwood JM; Department of Internal Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania., Lawson DH; Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia., Leming PD; Cincinnati Cancer Advisors, Cincinnati, Ohio., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia., Marghoob AA; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Mehnert JM; Department of Medical Oncology, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.; Rutgers Cancer Institute of New Jersey, New Brunswick., Ming ME; Department of Dermatology, Perelman School of Medicine University of Pennsylvania, Philadelphia., Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston., Polsky D; Department of Dermatology, Ronald O. Perelman Department of Dermatology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York University School of Medicine, New York, New York., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Smith EA; Department of Pathology, University of Utah, Salt Lake City., Sondak VK; Department of Cutaneous Oncology, Moffitt Cancer Center & Research Institute, Tampa, Florida.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa., Stark MS; The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia., Stein JA; Department of Dermatology, Ronald O. Perelman Department of Dermatology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York University School of Medicine, New York, New York., Thompson JA; Fred Hutchinson Cancer Research Center, Seattle, Washington.; Department of Oncology, University of Washington, Seattle.; Seattle Cancer Care Alliance, Seattle, Washington., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Venna SS; Inova Schar Cancer Institute, Department of Medicine, Virginia Commonwealth University, Fairfax., Wei ML; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.; Department of Dermatology, University of California, San Francisco.; Dermatology Service, Veterans Affairs Medical Center, San Francisco, California., Swetter SM; Stanford University Medical Center and Cancer Institute, Stanford, California.; Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California. |
| Source: | JAMA dermatology [JAMA Dermatol] 2020 Sep 01; Vol. 156 (9), pp. 1004-1011. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6084 |
|---|---|
| DOI: | 10.1001/jamadermatol.2020.1729 |
